Health Canada's reclassification of the levonorgestrel «morning - after pill» as a nonprescription
drug, thus permitting pharmacists to dispense this postcoital oral contraceptive directly to women who need it, when they need it, is welcome news (see
page 861).1 Less welcome is the «behind the counter» classification of levonorgestrel 0.75 mg (
Plan B) by the provinces, which makes consultation with a pharmacist mandatory for any woman seeking to avoid an unintended pregnancy in this way.